Skip to main content
Lester Kobzik, MD, Research, Mountain View, CA

LesterKobzikMD

Research Mountain View, CA

Professor of Pathology (Emeritus) Harvard U.

Dr. Kobzik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kobzik's full profile

Already have an account?

  • Office

    320 Logue Ave.
    Cellecta, Inc
    Mountain View, CA 94043
    Phone+1 650-938-3910

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1981 - 1986
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2017 - 2023
  • MA State Medical License
    MA State Medical License 1980 - 2019
  • American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

Press Mentions

  • BioAegis Therapeutics to Sponsor a Webinar, Below the Eyes of the Hippopotamus: The Expanding Spectrum of Auto- and Hyper- Inflammatory Diseases
    BioAegis Therapeutics to Sponsor a Webinar, Below the Eyes of the Hippopotamus: The Expanding Spectrum of Auto- and Hyper- Inflammatory DiseasesMay 10th, 2023
  • Dual-Promoter Lentiviral System Allows Inducible Expression of Noxious Proteins in Macrophages
    Dual-Promoter Lentiviral System Allows Inducible Expression of Noxious Proteins in MacrophagesOctober 18th, 2020
  • BioAegis Therapeutics Announces Publication: "Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Severe Influenza"
    BioAegis Therapeutics Announces Publication: "Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Severe Influenza"December 12th, 2019
  • Join now to see all